|
PE20152002A1
(es)
|
2013-05-01 |
2016-01-21 |
Isis Pharmaceuticals Inc |
Composiciones y metodos para modular la expresion de ttr y vhb
|
|
RS59182B1
(sr)
*
|
2014-05-01 |
2019-10-31 |
Ionis Pharmaceuticals Inc |
Kompozicije i postupci za modulaciju ekspresije faktora b komplementa
|
|
WO2015179693A1
(en)
|
2014-05-22 |
2015-11-26 |
Isis Pharmaceuticals, Inc. |
Conjugated antisense compounds and their use
|
|
WO2015188194A1
(en)
*
|
2014-06-06 |
2015-12-10 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for enhanced intestinal absorption of conjugated oligomeric compounds
|
|
ES2747842T3
(es)
|
2014-12-15 |
2020-03-11 |
Dicerna Pharmaceuticals Inc |
Acidos nucleicos de doble hebra modificados por ligando
|
|
WO2016196124A2
(en)
*
|
2015-05-29 |
2016-12-08 |
Ascendis Pharma Inc. |
Prodrugs comprising a pyroglutamate linker
|
|
US20180193471A1
(en)
*
|
2015-07-16 |
2018-07-12 |
Kyowa Hakko Kirin Co., Ltd. |
ß2GPI GENE EXPRESSION-SUPPRESSING NUCLEIC ACID CONJUGATE
|
|
CN105524124B
(zh)
*
|
2015-12-31 |
2018-10-30 |
天津英吉诺科技有限公司 |
一种n-乙酰氨基半乳糖的绿色合成方法
|
|
WO2017131236A1
(ja)
|
2016-01-29 |
2017-08-03 |
協和発酵キリン株式会社 |
核酸複合体
|
|
MX2018009854A
(es)
|
2016-03-07 |
2018-11-09 |
Arrowhead Pharmaceuticals Inc |
Ligandos dirigidos para compuestos terapeuticos.
|
|
CN109153697A
(zh)
*
|
2016-04-14 |
2019-01-04 |
豪夫迈·罗氏有限公司 |
三苯甲基-单-GalNAc化合物及其用途
|
|
US11390867B2
(en)
|
2016-04-29 |
2022-07-19 |
Nanyang Technological University |
G-quadruplex-containing antisense oligonucleotides
|
|
WO2018004004A1
(ja)
|
2016-06-30 |
2018-01-04 |
協和発酵キリン株式会社 |
核酸複合体
|
|
US11253601B2
(en)
|
2016-07-11 |
2022-02-22 |
Translate Bio Ma, Inc. |
Nucleic acid conjugates and uses thereof
|
|
WO2018013999A1
(en)
|
2016-07-15 |
2018-01-18 |
Am Chemicals Llc |
Non-nucleosidic solid supports and phosphoramidite building blocks for oligonucleotide synthesis
|
|
CN116832169A
(zh)
|
2016-09-02 |
2023-10-03 |
箭头药业股份有限公司 |
靶向配体
|
|
KR20190065341A
(ko)
|
2016-10-06 |
2019-06-11 |
아이오니스 파마수티컬즈, 인코포레이티드 |
올리고머 화합물들의 접합 방법
|
|
CN110536964A
(zh)
|
2017-03-10 |
2019-12-03 |
国立研究开发法人国立成育医疗研究中心 |
反义寡核苷酸和糖原贮积病Ia型预防或治疗用组合物
|
|
AU2018237139A1
(en)
*
|
2017-03-22 |
2019-10-17 |
The Regents Of The University Of California |
Modified oligonucleotides and therapeutic uses thereof
|
|
RS63836B1
(sr)
|
2017-04-05 |
2023-01-31 |
Silence Therapeutics Gmbh |
Proizvodi i sastavi
|
|
KR102677783B1
(ko)
|
2017-04-28 |
2024-06-21 |
쿄와 기린 가부시키가이샤 |
올리고뉴클레오티드 유도체 또는 그 염
|
|
TW201909925A
(zh)
*
|
2017-08-02 |
2019-03-16 |
日商協和醱酵麒麟有限公司 |
核酸複合體
|
|
TW201920668A
(zh)
*
|
2017-08-02 |
2019-06-01 |
日商協和醱酵麒麟有限公司 |
核酸複合體
|
|
CN111527207B
(zh)
*
|
2017-09-14 |
2024-04-26 |
詹森生物制药有限公司 |
GalNAc衍生物
|
|
WO2019105419A1
(zh)
*
|
2017-12-01 |
2019-06-06 |
苏州瑞博生物技术有限公司 |
一种核酸、含有该核酸的组合物与缀合物及制备方法和用途
|
|
KR20250107294A
(ko)
|
2017-12-01 |
2025-07-11 |
쑤저우 리보 라이프 사이언스 컴퍼니, 리미티드 |
핵산, 이를 포함하는 조성물과 컨쥬게이트, 및 그의 제조 방법과 용도
|
|
WO2019105403A1
(zh)
*
|
2017-12-01 |
2019-06-06 |
苏州瑞博生物技术有限公司 |
一种核酸、含有该核酸的组合物与缀合物及制备方法和用途
|
|
US11414661B2
(en)
|
2017-12-01 |
2022-08-16 |
Suzhou Ribo Life Science Co., Ltd. |
Nucleic acid, composition and conjugate containing nucleic acid, preparation method therefor and use thereof
|
|
WO2019105404A1
(zh)
*
|
2017-12-01 |
2019-06-06 |
苏州瑞博生物技术有限公司 |
一种核酸、含有该核酸的组合物与缀合物及制备方法和用途
|
|
WO2019105418A1
(zh)
*
|
2017-12-01 |
2019-06-06 |
苏州瑞博生物技术有限公司 |
双链寡核苷酸、含双链寡核苷酸的组合物与缀合物及制备方法和用途
|
|
JP7273417B2
(ja)
|
2017-12-01 |
2023-05-15 |
スーチョウ リボ ライフ サイエンス カンパニー、リミテッド |
核酸、当該核酸を含む組成物および複合体ならびに調製方法と使用
|
|
DK3732185T3
(da)
|
2017-12-29 |
2025-03-31 |
Suzhou Ribo Life Science Co Ltd |
Konjugater og fremstilling og anvendelse heraf
|
|
US12178855B2
(en)
|
2018-01-10 |
2024-12-31 |
Translate Bio Ma, Inc. |
Compositions and methods for facilitating delivery of synthetic nucleic acids to cells
|
|
CN111511915A
(zh)
|
2018-03-09 |
2020-08-07 |
第一三共株式会社 |
糖原病Ia型治疗药
|
|
WO2019193189A1
(en)
*
|
2018-04-05 |
2019-10-10 |
Silence Therapeutics Gmbh |
siRNAs WITH AT LEAST TWO LIGANDS AT DIFFERENT ENDS
|
|
MX2020011570A
(es)
|
2018-05-07 |
2020-11-24 |
Alnylam Pharmaceuticals Inc |
Administracion extrahepatica.
|
|
EP3842534A4
(en)
|
2018-08-21 |
2022-07-06 |
Suzhou Ribo Life Science Co., Ltd. |
NUCLEIC ACID, PHARMACEUTICAL COMPOSITION AND CONJUGATE WITH NUCLEIC ACID AND THEIR USE
|
|
WO2020063198A1
(zh)
*
|
2018-09-30 |
2020-04-02 |
苏州瑞博生物技术有限公司 |
一种siRNA缀合物及其制备方法和用途
|
|
GB2579253A
(en)
*
|
2018-11-28 |
2020-06-17 |
Pedanius Therapeutics Ltd |
Antibacterial antisense agents
|
|
AU2019390097A1
(en)
|
2018-11-30 |
2021-07-15 |
Kyowa Kirin Co., Ltd. |
Nucleic acid conjugate
|
|
JP7507495B2
(ja)
|
2018-12-28 |
2024-06-28 |
スーチョウ リボ ライフ サイエンス カンパニー、リミテッド |
核酸、当該核酸を含む組成物及び複合体ならびに調製方法と使用
|
|
GB201821269D0
(en)
|
2018-12-28 |
2019-02-13 |
Nippon Shinyaku Co Ltd |
Myostatin signal inhibitor
|
|
CN111377984B
(zh)
*
|
2018-12-29 |
2024-03-05 |
苏州瑞博生物技术股份有限公司 |
化合物和缀合物及其制备方法和用途
|
|
CN111377985B
(zh)
*
|
2018-12-29 |
2023-11-10 |
苏州瑞博生物技术股份有限公司 |
化合物和缀合物及其制备方法和用途
|
|
CN113330117B
(zh)
*
|
2019-01-18 |
2024-05-28 |
苏州瑞博生物技术股份有限公司 |
一种核酸、含有该核酸的组合物与缀合物及制备方法和用途
|
|
TWI863999B
(zh)
*
|
2019-05-22 |
2024-12-01 |
大陸商蘇州瑞博生物技術股份有限公司 |
ｓｉＲＮＡ綴合物、其用途及使用其之方法
|
|
WO2020233680A1
(zh)
|
2019-05-22 |
2020-11-26 |
苏州瑞博生物技术股份有限公司 |
核酸、药物组合物与缀合物及制备方法和用途
|
|
CA3139195A1
(en)
|
2019-05-22 |
2020-11-26 |
Suzhou Ribo Life Science Co., Ltd. |
Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use
|
|
EP3974530A4
(en)
|
2019-05-22 |
2023-07-12 |
Suzhou Ribo Life Science Co., Ltd. |
NUCLEIC ACID, PHARMACEUTICAL COMPOSITION, CONJUGATE, METHOD OF MANUFACTURE AND USE
|
|
CN111973619B
(zh)
*
|
2019-05-23 |
2024-01-30 |
苏州瑞博生物技术股份有限公司 |
核酸、含有该核酸的药物组合物与siRNA缀合物及制备方法和用途
|
|
CN111973618B
(zh)
*
|
2019-05-23 |
2024-02-02 |
苏州瑞博生物技术股份有限公司 |
核酸、药物组合物与siRNA缀合物及制备方法和用途
|
|
JP7610849B2
(ja)
|
2019-05-24 |
2025-01-09 |
スーチョウ リボ ライフ サイエンス カンパニー、リミテッド |
核酸、薬物組成物及び複合体ならびに調製方法と使用
|
|
WO2020238763A1
(zh)
|
2019-05-24 |
2020-12-03 |
苏州瑞博生物技术股份有限公司 |
核酸、药物组合物与缀合物及制备方法和用途
|
|
JP7614650B2
(ja)
|
2019-05-24 |
2025-01-16 |
スーチョウ リボ ライフ サイエンス カンパニー、リミテッド |
核酸、薬物組成物及び複合体並びに調製方法と使用
|
|
CN112007040B
(zh)
*
|
2019-05-31 |
2024-01-30 |
苏州瑞博生物技术股份有限公司 |
用于治疗乙型病毒性肝炎的联合用药物
|
|
US20230076803A1
(en)
|
2019-08-29 |
2023-03-09 |
Suzhou Ribo Life Science Co., Ltd. |
Compound and drug conjugate, and preparation method and use thereof
|
|
KR20220061972A
(ko)
|
2019-09-10 |
2022-05-13 |
다이이찌 산쿄 가부시키가이샤 |
간장 송달용 GalNAc-올리고뉴클레오티드 콘주게이트 및 제조 방법
|
|
CN115003330A
(zh)
|
2019-09-23 |
2022-09-02 |
科纳克斯资本 |
作为疫苗和诊断工具的新糖缀合物
|
|
EP4055166A2
(en)
*
|
2019-11-06 |
2022-09-14 |
Alnylam Pharmaceuticals, Inc. |
Extrahepatic delivery
|
|
MX2022006097A
(es)
*
|
2019-11-26 |
2022-10-18 |
Dtx Pharma Inc |
Compuesto que comprende un acido nucleico y un motivo de extension de la vida media.
|
|
CN112876534B
(zh)
*
|
2019-11-29 |
2024-02-09 |
苏州瑞博生物技术股份有限公司 |
肝靶向化合物及缀合物
|
|
US20230312635A1
(en)
*
|
2020-01-29 |
2023-10-05 |
Sumitomo Chemical Company, Limited |
Method for producing nucleic acid oligomer
|
|
CN111269279B
(zh)
*
|
2020-02-24 |
2022-08-05 |
陕西师范大学 |
一种在温和条件下制备卤代糖的方法
|
|
CA3172591A1
(en)
|
2020-03-24 |
2021-09-30 |
Douglas Anthony KERR |
Non-viral dna vectors and uses thereof for expressing gaucher therapeutics
|
|
IL296660A
(en)
|
2020-03-24 |
2022-11-01 |
Generation Bio Co |
Non-viral dna vectors and uses thereof for expressing factor ix therapeutics
|
|
CN113683651A
(zh)
*
|
2020-05-19 |
2021-11-23 |
上海京新生物医药有限公司 |
一种GalNAc中间体的制备方法
|
|
IL298406A
(en)
|
2020-05-22 |
2023-01-01 |
Wave Life Sciences Ltd |
Double stranded oligonucleotide compositions and methods relating thereto
|
|
AU2021288648A1
(en)
|
2020-06-10 |
2023-02-09 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Conjugate of double-stranded siRNA analogue
|
|
KR20230135585A
(ko)
|
2020-12-23 |
2023-09-25 |
플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 |
변형된 trem의 조성물 및 이의 용도
|
|
WO2022143531A1
(zh)
|
2020-12-29 |
2022-07-07 |
苏州瑞博生物技术股份有限公司 |
一种核酸、含有该核酸的药物组合物与siRNA缀合物及制备方法和用途
|
|
WO2022189861A1
(en)
|
2021-03-08 |
2022-09-15 |
Tollys |
Carbohydrate conjugates of tlr3 ligands and uses thereof
|
|
AU2022264509A1
(en)
|
2021-04-27 |
2023-12-14 |
Generation Bio Co. |
Non-viral dna vectors expressing therapeutic antibodies and uses thereof
|
|
EP4329884A1
(en)
|
2021-04-27 |
2024-03-06 |
Generation Bio Co. |
Non-viral dna vectors expressing anti-coronavirus antibodies and uses thereof
|
|
EP4341269A1
(en)
*
|
2021-05-20 |
2024-03-27 |
Olix US, Inc. |
Functional moieties and their uses and synthetic preparation
|
|
CN115572241B
(zh)
*
|
2021-06-21 |
2024-08-30 |
润佳（苏州）医药科技有限公司 |
双价化合物、偶联物及其用途
|
|
JPWO2023282344A1
(enExample)
|
2021-07-08 |
2023-01-12 |
|
|
|
WO2023282346A1
(ja)
|
2021-07-08 |
2023-01-12 |
日本新薬株式会社 |
析出抑制剤
|
|
IL310003A
(en)
|
2021-07-08 |
2024-03-01 |
Nippon Shinyaku Co Ltd |
Nephrotoxicity reducing agent
|
|
EP4372085A4
(en)
|
2021-07-16 |
2026-01-21 |
Suzhou Ribo Life Science Co Ltd |
Nucleic acid, composition and conjugate, container, preparation process and use
|
|
WO2023284763A1
(zh)
|
2021-07-16 |
2023-01-19 |
苏州瑞博生物技术股份有限公司 |
双链寡核苷酸、含双链寡核苷酸的组合物与缀合物及制备方法和用途
|
|
AU2022324471A1
(en)
|
2021-08-05 |
2024-02-15 |
Sanegene Bio Usa Inc. |
1'-alkyl modified ribose derivatives and methods of use
|
|
AU2022352676A1
(en)
|
2021-09-22 |
2024-03-14 |
Sanegene Bio Usa Inc. |
2'-alkyl or 3'- alkyl modified ribose derivatives for use in the in-vivo delivery of oligonucleotides
|
|
CA3233836A1
(en)
|
2021-10-05 |
2023-04-13 |
Weimin Wang |
Polyhydroxylated cyclopentane derivatives and methods of use
|
|
WO2023097251A1
(en)
*
|
2021-11-23 |
2023-06-01 |
Yale University |
Oligonucleotide-containing transcription factor targeting chimeras
|
|
JP2025508785A
(ja)
|
2022-02-22 |
2025-04-10 |
セーンジーン バイオ ユーエスエー インコーポレイティド |
５’修飾炭素環式リボヌクレオチド誘導体及び使用方法
|
|
CN120129745A
(zh)
|
2022-03-10 |
2025-06-10 |
日本新药株式会社 |
抗病毒反义低聚物
|
|
CN119072330A
(zh)
|
2022-03-14 |
2024-12-03 |
世代生物公司 |
异源初免加强疫苗组合物和使用方法
|
|
WO2023176863A1
(ja)
|
2022-03-16 |
2023-09-21 |
第一三共株式会社 |
ＲＮＡｉ活性を有する化学修飾オリゴヌクレオチド
|
|
JPWO2023176862A1
(enExample)
|
2022-03-16 |
2023-09-21 |
|
|
|
WO2023207615A1
(zh)
*
|
2022-04-26 |
2023-11-02 |
南京明德新药研发有限公司 |
一类含由天然核苷酸组成突出端的双链RNAi化合物
|
|
US20250346620A1
(en)
*
|
2022-04-28 |
2025-11-13 |
Dicerna Pharmaceuticals, Inc. |
Methods for synthesis of peracetylgalactosamine-1-pentanoic acid
|
|
WO2023220744A2
(en)
|
2022-05-13 |
2023-11-16 |
Alnylam Pharmaceuticals, Inc. |
Single-stranded loop oligonucleotides
|
|
EP4544043A1
(en)
|
2022-06-22 |
2025-04-30 |
Flagship Pioneering Innovations VI, LLC |
Compositions of modified trems and uses thereof
|
|
CN119654412A
(zh)
*
|
2022-06-27 |
2025-03-18 |
中美瑞康核酸技术(南通)研究院有限公司 |
激活补体因子h表达的寡核苷酸调节剂
|
|
EP4547683A2
(en)
|
2022-06-30 |
2025-05-07 |
Alnylam Pharmaceuticals, Inc. |
Cyclic-disulfide modified phosphate based oligonucleotide prodrugs
|
|
IL317824A
(en)
|
2022-07-11 |
2025-02-01 |
Sanegene Bio Usa Inc |
Ribose derivatives modified at the '2' position and methods of use
|
|
KR20250046303A
(ko)
|
2022-08-05 |
2025-04-02 |
사네진 바이오 유에스에이 인크. |
안지오텐시노겐 (agt)을 표적화하는 이중 가닥 rna 및 그의 사용 방법
|
|
WO2024040222A1
(en)
|
2022-08-19 |
2024-02-22 |
Generation Bio Co. |
Cleavable closed-ended dna (cedna) and methods of use thereof
|
|
WO2024081954A2
(en)
|
2022-10-14 |
2024-04-18 |
Sanegene Bio Usa Inc. |
Small interfering rna targeting c3 and uses thereof
|
|
AU2023404700A1
(en)
|
2022-12-02 |
2025-07-10 |
Shanghai Argo Biopharmaceutical Co., Ltd. |
Bicyclic abasic nucleic acid analogs and oligomeric compounds prepared therefrom
|
|
EP4638743A2
(en)
|
2022-12-19 |
2025-10-29 |
Sanegene Bio USA Inc. |
Small interfering rna targeting cfb and uses thereof
|
|
CN116178458A
(zh)
*
|
2022-12-26 |
2023-05-30 |
成都药明康德新药开发有限公司 |
一种糖苷化合物的合成
|
|
WO2024160204A1
(en)
*
|
2023-01-30 |
2024-08-08 |
Primelink Biotherapeutics (Suzhou) Co., Ltd. |
Polymer-oligonucleotide conjugates
|
|
WO2024175111A2
(en)
|
2023-02-24 |
2024-08-29 |
Suzhou Sanegene Bio Inc. |
Small interfering rna targeting hbv and uses thereof
|
|
WO2024186673A2
(en)
|
2023-03-03 |
2024-09-12 |
Sanegene Bio Usa Inc. |
Small interfering rna targeting apoc3 and uses thereof
|
|
JP2026507286A
(ja)
|
2023-03-10 |
2026-02-27 |
スーチョウ リボ ライフ サイエンス カンパニー、リミテッド |
医薬組成物及びその使用
|
|
EP4709855A2
(en)
|
2023-05-12 |
2026-03-18 |
Alnylam Pharmaceuticals, Inc. |
Single-stranded loop oligonucleotides
|
|
EP4706646A1
(en)
|
2023-06-01 |
2026-03-11 |
Sunshine Lake Pharma Co., Ltd. |
Novel double-stranded sirna, conjugate thereof, and use thereof
|
|
US20250027089A1
(en)
|
2023-06-21 |
2025-01-23 |
Sanegene Bio Usa Inc. |
Double stranded rna targeting proprotein convertase subtilisin kexin 9 (pcsk9) and methods of use thereof
|
|
CN119219716A
(zh)
*
|
2023-06-30 |
2024-12-31 |
上海维申医药有限公司 |
新型GalNAc的靶向递送片段及其制备和应用
|
|
WO2025016441A1
(zh)
*
|
2023-07-19 |
2025-01-23 |
上海维申医药有限公司 |
新型GalNAc的靶向递送片段及其制备和应用
|
|
WO2025024523A1
(en)
|
2023-07-24 |
2025-01-30 |
Sanegene Bio Usa Inc. |
Lipid-based enhancement agent for rna delivery and therapy
|
|
AU2024321710A1
(en)
|
2023-08-04 |
2026-03-05 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Double-stranded ribonucleic acid targeting pd-l1
|
|
WO2025031444A1
(zh)
|
2023-08-09 |
2025-02-13 |
北京福元医药股份有限公司 |
抑制DGAT2基因表达的siRNA、siRNA缀合物或其前药和药物组合物及用途
|
|
WO2025042786A1
(en)
|
2023-08-18 |
2025-02-27 |
Flagship Pioneering Innovations Vi, Llc |
Compositions comprising circular polyribonucleotides and uses thereof
|
|
CN117384226B
(zh)
*
|
2023-09-14 |
2025-12-26 |
苏州盛诺维生物科技有限公司 |
一种GalNAc类化合物的合成工艺
|
|
AU2024369609A1
(en)
|
2023-10-31 |
2025-12-11 |
Korro Bio, Inc. |
Oligonucleotides comprising phosphoramidate internucleotide linkages
|
|
WO2025111526A1
(en)
|
2023-11-22 |
2025-05-30 |
Flagship Pioneering Innovations Vii, Llc |
Methods and compositions for treating non-alcoholic fatty liver disease
|
|
WO2025140299A1
(zh)
*
|
2023-12-26 |
2025-07-03 |
广东东阳光药业股份有限公司 |
一种新型的化合物及其用途
|
|
TW202546227A
(zh)
|
2024-01-18 |
2025-12-01 |
荷蘭商Ｐｒｏｑｒ治療上市公司Ｉｉ |
用於治療賀勒氏症候群（ｈｕｒｌｅｒ ｓｙｎｄｒｏｍｅ）的反義寡核苷酸
|
|
WO2025207934A1
(en)
|
2024-03-28 |
2025-10-02 |
Lycia Therapeutics, Inc. |
Lysosomal targeting bifunctional molecules for degradation of thyroid stimulating hormone receptor autoantibodies
|
|
WO2025228441A2
(en)
|
2024-04-30 |
2025-11-06 |
Sanegene Bio Usa Inc. |
Small interfering rna targeting inhbe and uses thereof
|
|
CN118146284B
(zh)
*
|
2024-05-08 |
2024-07-26 |
北京悦康科创医药科技股份有限公司 |
一种GalNAc化合物、其与寡核苷酸缀合物及制备方法
|
|
WO2025245188A2
(en)
|
2024-05-21 |
2025-11-27 |
Flagship Pioneering Innovations Vii, Llc |
Methods of treating liver steatosis and non-alcoholic fatty liver disease
|
|
WO2026017140A2
(en)
|
2024-07-18 |
2026-01-22 |
Sanegene Bio Usa Inc. |
Small interfering rna targeting fxi and uses thereof
|
|
WO2026041067A2
(en)
|
2024-08-20 |
2026-02-26 |
Sanegene Bio Usa Inc. |
Small interfering rna targeting myostatin (mstn) and uses thereof
|
|
WO2026046411A1
(en)
|
2024-09-02 |
2026-03-05 |
Sanegene Bio Usa Inc. |
Small interfering rna targeting plasminogen (plg) and uses thereof
|
|
CN121081660A
(zh)
*
|
2025-02-21 |
2025-12-09 |
上海辉棵生物医药有限公司 |
一种靶向递送系统及其核酸缀合物的制备方法与用途
|